Uravi Defence & Technology Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 20, 2025, 7:11 pm

Market Cap	524 Cr.
Current Price	484
High / Low	588/292
Stock P/E	225
Book Value	42.2
Dividend Yield	0.00 %
ROCE	%
ROE	%
Face Value	10.0
PEG Ratio	0.00

Quick Insight

Uravi Defence & Technology Ltd, with a market cap of ₹531 Cr. and a share price of ₹500, presents a challenging P/E ratio of 216, indicating high investor expectations. The company's ROE and ROCE figures, along with an OPM of 15.35%, suggest room for improvement in operational efficiency and profitability. With Promoters holding a significant 70.30% stake and minimal FII interest at 6.47%, the stock's performance heavily relies on domestic investor sentiment. A concerning CCC of 511.92 days and substantial borrowings of ₹25.88 Cr raise liquidity and solvency red flags, despite a healthy ICR of 3.54x. Investors should closely monitor operational performance and debt levels to gauge the company's financial health and growth prospects effectively.

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Uravi Defence & Technology Ltd

Competitors of Uravi Defence & Technology Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Varroc Engineering Ltd	8,454 Cr.	553	649/365	44.8	102	0.18 %	17.1 %	7.37 %	1.00
Uravi Defence & Technology Ltd	524 Cr.	484	588/292	225	42.2	0.00 %	%	%	10.0
Lumax Industries Ltd	3,657 Cr.	3,892	4,150/1,960	25.8	828	0.90 %	16.4 %	19.3 %	10.0
Fiem Industries Ltd	5,478 Cr.	2,083	2,157/1,156	26.0	394	1.44 %	27.8 %	21.0 %	10.0
Industry Average	4,528.25 Cr	1,753.00		80.40	341.55	0.63%	20.43%	15.89%	7.75

All Competitor Stocks of Uravi Defence & Technology Ltd

Quarterly Result

Metric	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Sales	11.12	10.02	11.40	10.02
Expenses	9.62	9.08	9.65	8.80
Operating Profit	1.50	0.94	1.75	1.22
OPM %	13.49%	9.38%	15.35%	12.18%
Other Income	0.07	0.37	0.33	0.40
Interest	0.57	0.40	0.39	0.39
Depreciation	0.55	0.55	0.51	0.52
Profit before tax	0.45	0.36	1.18	0.71
Tax %	33.33%	25.00%	31.36%	25.35%
Net Profit	0.35	0.71	0.93	0.53
EPS in Rs	0.32	0.65	0.76	0.39

Last Updated: August 20, 2025, 1:45 am

Below is a detailed analysis of the quarterly data for Uravi Defence & Technology Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

For Sales, as of Jun 2025, the value is 10.02 Cr.. The value appears to be declining and may need further review. It has decreased from 11.40 Cr. (Mar 2025) to 10.02 Cr., marking a decrease of 1.38 Cr..
For Expenses, as of Jun 2025, the value is 8.80 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 9.65 Cr. (Mar 2025) to 8.80 Cr., marking a decrease of 0.85 Cr..
For Operating Profit, as of Jun 2025, the value is 1.22 Cr.. The value appears to be declining and may need further review. It has decreased from 1.75 Cr. (Mar 2025) to 1.22 Cr., marking a decrease of 0.53 Cr..
For OPM %, as of Jun 2025, the value is 12.18%. The value appears to be declining and may need further review. It has decreased from 15.35% (Mar 2025) to 12.18%, marking a decrease of 3.17%.
For Other Income, as of Jun 2025, the value is 0.40 Cr.. The value appears strong and on an upward trend. It has increased from 0.33 Cr. (Mar 2025) to 0.40 Cr., marking an increase of 0.07 Cr..
For Interest, as of Jun 2025, the value is 0.39 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.39 Cr..
For Depreciation, as of Jun 2025, the value is 0.52 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.51 Cr. (Mar 2025) to 0.52 Cr., marking an increase of 0.01 Cr..
For Profit before tax, as of Jun 2025, the value is 0.71 Cr.. The value appears to be declining and may need further review. It has decreased from 1.18 Cr. (Mar 2025) to 0.71 Cr., marking a decrease of 0.47 Cr..
For Tax %, as of Jun 2025, the value is 25.35%. The value appears to be improving (decreasing) as expected. It has decreased from 31.36% (Mar 2025) to 25.35%, marking a decrease of 6.01%.
For Net Profit, as of Jun 2025, the value is 0.53 Cr.. The value appears to be declining and may need further review. It has decreased from 0.93 Cr. (Mar 2025) to 0.53 Cr., marking a decrease of 0.40 Cr..
For EPS in Rs, as of Jun 2025, the value is 0.39. The value appears to be declining and may need further review. It has decreased from 0.76 (Mar 2025) to 0.39, marking a decrease of 0.37.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: August 9, 2025, 9:53 am

Metric	Mar 2025
Sales	43.63
Expenses	37.85
Operating Profit	5.78
OPM %	13.25%
Other Income	0.97
Interest	1.91
Depreciation	2.05
Profit before tax	2.79
Tax %	30.11%
Net Profit	2.55
EPS in Rs	2.24
Dividend Payout %	0.00%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year
YoY Net Profit Growth (%)
Change in YoY Net Profit Growth (%)

No data available for trend analysis.

Growth

Compounded Sales Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	%

Stock Price CAGR
10 Years:	%
5 Years:	57%
3 Years:	59%
1 Year:	-6%

Return on Equity
10 Years:	%
5 Years:	%
3 Years:	%
Last Year:	%

Last Updated: Unknown

Balance Sheet

Last Updated: August 9, 2025, 9:53 am

Month	Mar 2025
Equity Capital	11.26
Reserves	35.10
Borrowings	25.88
Other Liabilities	16.53
Total Liabilities	88.77
Fixed Assets	19.58
CWIP	2.71
Investments	0.19
Other Assets	66.29
Total Assets	88.77

Below is a detailed analysis of the balance sheet data for Uravi Defence & Technology Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Equity Capital, as of Mar 2025, the value is 11.26 Cr.. No previous period data is available for comparison.
For Reserves, as of Mar 2025, the value is 35.10 Cr.. No previous period data is available for comparison.
For Borrowings, as of Mar 2025, the value is 25.88 Cr.. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. No previous period data is available for comparison.
For Other Liabilities, as of Mar 2025, the value is 16.53 Cr.. No previous period data is available for comparison.
For Total Liabilities, as of Mar 2025, the value is 88.77 Cr.. No previous period data is available for comparison.
For Fixed Assets, as of Mar 2025, the value is 19.58 Cr.. No previous period data is available for comparison.
For CWIP, as of Mar 2025, the value is 2.71 Cr.. No previous period data is available for comparison.
For Investments, as of Mar 2025, the value is 0.19 Cr.. No previous period data is available for comparison.
For Other Assets, as of Mar 2025, the value is 66.29 Cr.. No previous period data is available for comparison.
For Total Assets, as of Mar 2025, the value is 88.77 Cr.. No previous period data is available for comparison.

Notably, the Reserves (35.10 Cr.) exceed the Borrowings (25.88 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2025
Cash from Operating Activity +	-2.78
Cash from Investing Activity +	-0.94
Cash from Financing Activity +	17.96
Net Cash Flow	14.23

Free Cash Flow

Month	Mar 2025
Free Cash Flow	-20.10

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2025
Debtor Days	119.97
Inventory Days	453.33
Days Payable	61.37
Cash Conversion Cycle	511.92
Working Capital Days	122.81
ROCE %

Financial Efficiency Indicators Chart

No valid data available for the Shareholding

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 25
FaceValue	10.00
Basic EPS (Rs.)	2.31
Diluted EPS (Rs.)	2.25
Cash EPS (Rs.)	3.55
Book Value[Excl.RevalReserv]/Share (Rs.)	46.91
Book Value[Incl.RevalReserv]/Share (Rs.)	46.91
Revenue From Operations / Share (Rs.)	38.75
PBDIT / Share (Rs.)	5.99
PBIT / Share (Rs.)	4.17
PBT / Share (Rs.)	2.48
Net Profit / Share (Rs.)	1.73
NP After MI And SOA / Share (Rs.)	2.26
PBDIT Margin (%)	15.46
PBIT Margin (%)	10.76
PBT Margin (%)	6.39
Net Profit Margin (%)	4.46
NP After MI And SOA Margin (%)	5.83
Return on Networth / Equity (%)	4.81
Return on Capital Employeed (%)	8.54
Return On Assets (%)	2.86
Long Term Debt / Equity (X)	0.02
Total Debt / Equity (X)	0.48
Current Ratio (X)	1.90
Quick Ratio (X)	1.11
Interest Coverage Ratio (X)	3.54
Interest Coverage Ratio (Post Tax) (X)	2.02
Enterprise Value (Cr.)	404.69
EV / Net Operating Revenue (X)	9.28
EV / EBITDA (X)	59.98
MarketCap / Net Operating Revenue (X)	9.05
Price / BV (X)	7.47
Price / Net Operating Revenue (X)	9.05
EarningsYield	0.01

After reviewing the key financial ratios for Uravi Defence & Technology Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. No previous period data is available for comparison.
For Basic EPS (Rs.), as of Mar 25, the value is 2.31. This value is below the healthy minimum of 5. No previous period data is available for comparison.
For Diluted EPS (Rs.), as of Mar 25, the value is 2.25. This value is below the healthy minimum of 5. No previous period data is available for comparison.
For Cash EPS (Rs.), as of Mar 25, the value is 3.55. This value is within the healthy range. No previous period data is available for comparison.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 46.91. No previous period data is available for comparison.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 46.91. No previous period data is available for comparison.
For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 38.75. No previous period data is available for comparison.
For PBDIT / Share (Rs.), as of Mar 25, the value is 5.99. This value is within the healthy range. No previous period data is available for comparison.
For PBIT / Share (Rs.), as of Mar 25, the value is 4.17. This value is within the healthy range. No previous period data is available for comparison.
For PBT / Share (Rs.), as of Mar 25, the value is 2.48. This value is within the healthy range. No previous period data is available for comparison.
For Net Profit / Share (Rs.), as of Mar 25, the value is 1.73. This value is below the healthy minimum of 2. No previous period data is available for comparison.
For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 2.26. This value is within the healthy range. No previous period data is available for comparison.
For PBDIT Margin (%), as of Mar 25, the value is 15.46. This value is within the healthy range. No previous period data is available for comparison.
For PBIT Margin (%), as of Mar 25, the value is 10.76. This value is within the healthy range. No previous period data is available for comparison.
For PBT Margin (%), as of Mar 25, the value is 6.39. This value is below the healthy minimum of 10. No previous period data is available for comparison.
For Net Profit Margin (%), as of Mar 25, the value is 4.46. This value is below the healthy minimum of 5. No previous period data is available for comparison.
For NP After MI And SOA Margin (%), as of Mar 25, the value is 5.83. This value is below the healthy minimum of 8. No previous period data is available for comparison.
For Return on Networth / Equity (%), as of Mar 25, the value is 4.81. This value is below the healthy minimum of 15. No previous period data is available for comparison.
For Return on Capital Employeed (%), as of Mar 25, the value is 8.54. This value is below the healthy minimum of 10. No previous period data is available for comparison.
For Return On Assets (%), as of Mar 25, the value is 2.86. This value is below the healthy minimum of 5. No previous period data is available for comparison.
For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. No previous period data is available for comparison.
For Total Debt / Equity (X), as of Mar 25, the value is 0.48. This value is within the healthy range. No previous period data is available for comparison.
For Current Ratio (X), as of Mar 25, the value is 1.90. This value is within the healthy range. No previous period data is available for comparison.
For Quick Ratio (X), as of Mar 25, the value is 1.11. This value is within the healthy range. No previous period data is available for comparison.
For Interest Coverage Ratio (X), as of Mar 25, the value is 3.54. This value is within the healthy range. No previous period data is available for comparison.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.02. This value is below the healthy minimum of 3. No previous period data is available for comparison.
For Enterprise Value (Cr.), as of Mar 25, the value is 404.69. No previous period data is available for comparison.
For EV / Net Operating Revenue (X), as of Mar 25, the value is 9.28. This value exceeds the healthy maximum of 3. No previous period data is available for comparison.
For EV / EBITDA (X), as of Mar 25, the value is 59.98. This value exceeds the healthy maximum of 15. No previous period data is available for comparison.
For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 9.05. This value exceeds the healthy maximum of 3. No previous period data is available for comparison.
For Price / BV (X), as of Mar 25, the value is 7.47. This value exceeds the healthy maximum of 3. No previous period data is available for comparison.
For Price / Net Operating Revenue (X), as of Mar 25, the value is 9.05. This value exceeds the healthy maximum of 3. No previous period data is available for comparison.
For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. No previous period data is available for comparison.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Uravi Defence & Technology Ltd as of August 21, 2025 is: 1,162.19

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of August 21, 2025, Uravi Defence & Technology Ltd is Undervalued by 140.12% compared to the current share price 484.00

Default values used*: Default value of 15% for ROE is used

Intrinsic Value of Uravi Defence & Technology Ltd as of August 21, 2025 is: 1,162.19

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of August 21, 2025, Uravi Defence & Technology Ltd is Undervalued by 140.12% compared to the current share price 484.00

Default values used*: Default value of 15% for ROE is used

Last 5 Year EPS CAGR: 0.00%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The company has higher reserves (35.10 cr) compared to borrowings (25.88 cr), indicating strong financial stability. The company has shown consistent growth in sales (43.63 cr) and profit (2.79 cr) over the years.	The stock has a low average ROCE of 0.00%, which may not be favorable. The stock has a high average Working Capital Days of 122.81, which may not be favorable. The stock has a high average Cash Conversion Cycle of 511.92, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Uravi Defence & Technology Ltd:
1. Net Profit Margin: 4.46%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 8.54% (Industry Average ROCE: 20.43%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 4.81% (Industry Average ROE: 15.89%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 2.02
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 1.11
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 225 (Industry average Stock P/E: 80.4)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.48
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Uravi Defence and Technology Ltd. is a Public Limited Listed company incorporated on 19/04/2014 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L31500MH2004PLC145760 and registration number is 145760. Currently Company is involved in the business activities of Manufacture of electric lighting equipment. Company's Total Operating Revenue is Rs. 41.35 Cr. and Equity Capital is Rs. 11.26 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Auto Ancl - Equipment Lamp	Shop No. 329 Avior, Nirmal Galaxy, Mumbai Maharashtra 400080	info@uravilamps.com http://www.uravilamps.com

Management
Name	Position Held
Mr. Niraj Damji Gada	Managing Director & CEO
Mr. Kaushik Damji Gada	WholeTime Director & CFO
Mr. Brijesh Aggarwal	Non Executive Director
Ms. Shreya Ramkrishnan	Ind. Non-Executive Director
Mr. Sreedhar Ramachandran Ayalur	Ind. Non-Executive Director
Mr. Niken Shah	Ind. Non-Executive Director

FAQ

What is the intrinsic value of Uravi Defence & Technology Ltd?

Uravi Defence & Technology Ltd's intrinsic value (as of 20 August 2025) is ₹1162.19 which is 140.12% higher the current market price of ₹484.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹524 Cr. market cap, FY2025-2026 high/low of 588/292, reserves of ₹35.10 Cr, and liabilities of ₹88.77 Cr.

What is the Market Cap of Uravi Defence & Technology Ltd?

The Market Cap of Uravi Defence & Technology Ltd is 524 Cr..

What is the current Stock Price of Uravi Defence & Technology Ltd as on 20 August 2025?

The current stock price of Uravi Defence & Technology Ltd as on 20 August 2025 is 484.

What is the High / Low of Uravi Defence & Technology Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Uravi Defence & Technology Ltd stocks is 588/292.

What is the Stock P/E of Uravi Defence & Technology Ltd?

The Stock P/E of Uravi Defence & Technology Ltd is 225.

What is the Book Value of Uravi Defence & Technology Ltd?

The Book Value of Uravi Defence & Technology Ltd is 42.2.

What is the Dividend Yield of Uravi Defence & Technology Ltd?

The Dividend Yield of Uravi Defence & Technology Ltd is 0.00 %.

What is the ROCE of Uravi Defence & Technology Ltd?

The ROCE of Uravi Defence & Technology Ltd is %.

What is the ROE of Uravi Defence & Technology Ltd?

The ROE of Uravi Defence & Technology Ltd is %.

What is the Face Value of Uravi Defence & Technology Ltd?

The Face Value of Uravi Defence & Technology Ltd is 10.0.